Shanghai Rendu Biotechnology Co. Ltd. A (688193) — Net Asset Quality Index
Shanghai Rendu Biotechnology Co. Ltd. A (688193) has a Net Asset Quality Index of 93.3% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥984.02 Million minus total liabilities of CN¥65.45 Million yields net assets of CN¥918.58 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check asset resilience ratio of Shanghai Rendu Biotechnology Co. Ltd. A to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Shanghai Rendu Biotechnology Co. Ltd. A Net Asset Quality Index Over Time (2019–2025)
This chart shows how Shanghai Rendu Biotechnology Co. Ltd. A's Net Asset Quality Index has evolved across 7 annual periods from 2019 to 2025. As of March 2026, the index stands at 93.3%, representing net assets of CN¥918.58 Million against total assets of CN¥984.02 Million CNY. See working capital to net assets of Shanghai Rendu Biotechnology Co. Ltd. A to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Shanghai Rendu Biotechnology Co. Ltd. A (2019–2025)
The table below presents the year-by-year Net Asset Quality Index for Shanghai Rendu Biotechnology Co. Ltd. A from 2019 to 2025, covering 7 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 688193 company net worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 92.3% | CN¥913.91 Million | CN¥990.17 Million | CN¥76.26 Million | ▲ +0.6 pp |
| 2024 | 91.7% | CN¥911.88 Million | CN¥994.36 Million | CN¥82.48 Million | ▲ +0.4 pp |
| 2023 | 91.3% | CN¥962.74 Million | CN¥1.05 Billion | CN¥91.97 Million | ▲ +3.0 pp |
| 2022 | 88.3% | CN¥961.38 Million | CN¥1.09 Billion | CN¥127.34 Million | ▲ +12.3 pp |
| 2021 | 76.0% | CN¥287.75 Million | CN¥378.61 Million | CN¥90.86 Million | ▲ +6.8 pp |
| 2020 | 69.2% | CN¥215.03 Million | CN¥310.79 Million | CN¥95.75 Million | ▼ -11.3 pp |
| 2019 | 80.5% | CN¥150.66 Million | CN¥187.07 Million | CN¥36.41 Million | — |